SAN DIEGO, CA -- (MARKET WIRE) -- Apr 29, 2009 -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific business intelligence software and services, today announced that Dr. Frank Brown, Chief Science Officer of Accelrys, will be presenting at the Nanotech Conference being held at the George R. Brown Convention Center in Houston, Texas, from May 3 to May 7, 2009. In a session titled "Scientific Business Intelligence for Nanotechnology" scheduled for Monday, May 4 at 1:30 p.m., Dr. Brown will address the challenges in integrating data and applications to help scientists and engineers make more informed decisions. He will also address how to use the same systems to better collaborate and share information across the enterprise.

Nanotech 2009 is the largest international nanotechnology conference and trade show in the world. The conference brings together specialists from a wide range of fields of science, technology and business. For more information on the conference, visit http://www.nsti.org/Nanotech2009/

About Accelrys, Inc.

Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. Accelrys has a vast portfolio of computer-aided design modeling and simulation offerings which assist customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Its scientific business intelligence platform underlies the company's computer-aided design modeling and simulation offerings. The Accelrys platform can be used with both Accelrys and competitive products, as well as with customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit http://accelrys.com/

Forward-Looking Statements

This press release contains forward-looking statements. Such statements, including statements relating to the Company's products, their features, and their impact upon our customers' organizations, are subject to risks and uncertainties including, but not limited to, the risk that our products will not be successfully developed, achieve market acceptance, have the anticipated impact upon our customers' organizations, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

---

---

 Be the first to review this article